About Careers MedBlog Contact us

Genetically Engineered Virus to Fight Cancer Developed

by Medindia Content Team on October 27, 2007 at 1:34 PM
Font : A-A+

Genetically Engineered Virus to Fight Cancer Developed

A genetically engineered virus is able to destroy cancer cells in animals and human tissue in laboratory tests, say U.S. scientists.

In a study published Friday in the Journal of Clinical Investigation, scientists at Jennerex Biotherapeutics in San Francisco said they had been able to harness the killer instinct of a virus used to vaccinate people against smallpox to make it zero in on tumours in both rabbits and mice.


Known as poxvirus, the lab-grown virus can spread extremely quickly within tissues in the body. The virus was engineered to attack certain cancer cells that have a specific protein, EGFR. The modified virus was then injected under the skin of lab animals with cancer tumours. Scientists found that the virus remained in the tumours for at least 10 days, showing that the hosts' antiviral immune responses did not destroy it. They also discovered that the normal tissues in the animals' bodies were not infected with the virus.

"Dramatic therapeutic effects against large primary tumours were demonstrated following systemic delivery," reads the report.

The researchers cautioned that repeated use of the virus in one patient as an anti-tumour agent may not work if a cancer patient has had previous exposure to the virus and developed antibodies to it.

However, they are buoyed by the fact that a repeat injection of the virus into animals six weeks after the initial injection decreased the size of the tumours in three of the four test subjects.

"Initial results indicate that an anti-tumour effect is feasible in previously immunized individuals," reads the report.

Tests on human samples in the lab, which included ovarian, muscle, pancreatic, breast, and lung cancer cells, also showed the virus killed cancerous cells rapidly.

Researchers believe the treatment holds promise for human cancers and suggest clinical trials in humans go ahead.

Source: Medindia


Recommended Reading

Latest Cancer News

Is Adding Ribociclib to Hormone Therapy Improves Breast Cancer Outcomes
In patients with breast cancer combination therapy had increased invasive disease-free survival compared to those who were treated with the hormone therapy alone.
Antibody Treatment Proves Effective for Bile Duct Cancers
An antibody treatment helped shrink tumors in some patients with bile duct cancers.
Link Between Gut Microbiome and Precancerous Colon Polyps Identified
Comprehending the association between the gut microbiome and polyp growth sheds insights into potential screenings and treatments.
 Analyzing Paediatric Brain Tumours Provide Data for Cancer Research
The first large-scale, collaborative, open analysis of genomic data provides a cloud-based resource for researchers looking for more comprehensive data on pediatric brain tumors.
Cancer Drugs to be Tested in Orbit During American Private Astronaut Mission
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Genetically Engineered Virus to Fight Cancer Developed Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests